WeightWatchers' CEO said on Wednesday it planned to offer Novo Nordisk's much-anticipated Wegovy in pill form if it is ...

WeightWatchers' CEO said on Wednesday it plans to sell Novo Nordisk's much-anticipated Wegovy in pill form if it is launched ...

A new study suggests GLP-1 receptor agonists like Ozempic and Wegovy may significantly improve colon cancer survival rates.

Scientists have known that obesity and metabolic dysfunction can make cancers more aggressive. Tumors thrive in bodies ...

WeightWatchers has announced its plans to sell Novo Nordisk 's highly anticipated Wegovy in pill form, should it launch in ...

Shares of Mangoceuticals surged 28% ‌to $2.25 in premarket trading. U.S. regulations allow compounding pharmacies to copy ...

The benefit leaders emphasized that GLP-1s are just one part of the equation in addressing weight loss. Programs such as ...

GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the study ...

How Ozempic Is Changing Thanksgiving According to the independent research and polling source KFF, one in eight Americans reported taking a GLP-1 receptor agonist ...

The comedian shared snaps of herself rocking a red strapless mini dress and a pair of black slingback heels via Instagram.

Novo Nordisk maintains strong growth prospects, driven by obesity treatment market expansion. See why NVO stock is a strong ...

(Reuters) -Metsera shareholders on Thursday approved Pfizer's takeover offer worth up to $10 billion, allowing the U.S.